Intravitreal Pegaptanib in Ischemic CRVO Refractory Exudative Macular Detachment
VEGF drugs for the treatment of macular edema (ME) following Central Retinal Vein Occlusion (CRVO), up to 1-year followup. There are no randomized clinical trial data on anti-VEGF ... agents in ischemic CRVO-ME and the…

